The discovery that MMR defects predispose to cancer (Lynch syndrome) highlighted the relevance of MMR in human disease and renewed the interest in MMR proteins, their structure, mechanisms of action and gene variants that may contribute to the disease (Boland and Goel, 2010). This evidence concerns the gene MRC1 and cancer.